2017 Press Releases

January 11, 2017 at 11:00 a.m. PTIdera Pharmaceuticals, Inc. at the J.P. Morgan Healthcare Conference
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
Feb 24, 2017Idera Pharmaceuticals Presents Update from Ongoing Phase 1 Dose Escalation Clinical Trial of Intratumoral IMO-2125 in Combination with Ipilimumab in Metastatic Melanoma Patients Refractory to Anti-PD-1 Treatment at the 2017 ASCO-SITC Clinical Immuno-Oncology SymposiumRead MoreFeb 06, 2017Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early DevelopmentRead MoreJan 04, 2017Idera to Present at the 35th Annual J.P. Morgan Healthcare ConferenceRead More